• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AMT
Click for more information
0.00% 2.9¢

ALLEGRA MEDICAL TECHNOLOGIES LIMITED - Announcements

Market Cap $3.468M  ! watchlist Created with Sketch. Add to my watchlist

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a... Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AMT Half Yearly Report and AccountsPRICE SENSITIVE21/02/19
AMT Allegra Targets USA MarketPRICE SENSITIVE21/11/18
AMT Results of Meeting31/10/18
AMT Notice of Annual General Meeting/Proxy Form01/10/18
AMT Appendix 4G and Corporate Governance Statement12/09/18
AMT Annual Report to shareholders11/09/18
AMT Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE23/08/18
AMT Sr-HT-Gahnite to be used with kangaroo derived tendonsPRICE SENSITIVE03/08/18
AMT Allegra awarded MTPConnect BioMedTech Horizons GrantPRICE SENSITIVE18/04/18
AMT Initial Director's Interest Notice14/03/18
AMT Director Appointment07/03/18
AMT Half Yearly Report and AccountsPRICE SENSITIVE22/02/18
AMT Allegra to distribute the LINK product rangePRICE SENSITIVE14/12/17
AMT Appendix 3B08/12/17
AMT Change of Director's Interest Notice16/11/17
AMT Change of Director's Interest Notice16/11/17
AMT Change of Director's Interest Notice16/11/17
AMT Appendix 3B and Section 708A(5)(e) Notification09/11/17
AMT Private PlacementPRICE SENSITIVE09/11/17
AMT Results of Meeting25/10/17
AMT Allegra Orthopaedics Limited Business UpdatePRICE SENSITIVE25/10/17
AMT Becoming a substantial holder05/10/17
AMT Notice of Annual General Meeting/Proxy Form25/09/17
AMT Annual Report to shareholders25/09/17
AMT Change in substantial holding22/09/17
AMT Section 708A(5)(e) Notification18/09/17
AMT Appendix 3B13/09/17
AMT Private PlacementPRICE SENSITIVE08/09/17
AMT Appendix 4G30/08/17
AMT Appendix 4E and Annual ReportPRICE SENSITIVE29/08/17
AMT Sr-HT-Gahnite Bone Substitute Project UpdatePRICE SENSITIVE25/08/17
AMT Allegra signs collaboration agreementPRICE SENSITIVE17/08/17
AMT Change of Director's Interest Notice20/04/17
AMT Change of Director's Interest Notice20/04/17
AMT Results of Non-Renounceable Rights Issue12/04/17
AMT Rights Issue to close on 7 April 201704/04/17
AMT Notice under section 708AA of the Corporations Act16/03/17
AMT Rights Issue Letter to Shareholders10/03/17
AMT Rights Issue Offer DocumentPRICE SENSITIVE09/03/17
AMT Rights Issue Letter to Ineligible Shareholders09/03/17
AMT Notice under section 708AA of the Corporations Act09/03/17
AMT Change of Director's Interest Notice03/03/17
AMT Change in substantial holding27/02/17
AMT Appendix 3B - Rights Issue23/02/17
AMT Non-Renounceable Rights IssuePRICE SENSITIVE23/02/17
AMT Half Yearly Report and AccountsPRICE SENSITIVE23/02/17
AMT Sr-HT-Gahnite Bone Substitute Project updatePRICE SENSITIVE10/02/17
AMT Company Secretary Appointment/Resignation19/01/17
AMT Cleansing Statement-Share Placement13/12/16
AMT Appendix 3B13/12/16
AMT Results of Annual General Meeting30/11/16
AMT AGM-Business Update30/11/16
AMT Appointment of Auditor23/11/16
AMT Business Update-AMT.AX PRICE SENSITIVE31/10/16
AMT AGM- Item 6-Independent Expert's Report-AMT.AX 28/10/16
AMT AGM-Proxy Form-AMT.AX 28/10/16
AMT Notice of Annual General Meeting-AMT.AX 28/10/16
AMT Conditional Placement-AMT.AX PRICE SENSITIVE17/10/16
AMT Update on Bone Substitute Project-AMT.AX PRICE SENSITIVE20/09/16
AMT Appendix 3B-AMT.AX 20/09/16
AMT Appendix 4G-AMT.AX 30/08/16
AMT Appendix 4E and Annual Report-AMT.AX PRICE SENSITIVE30/08/16
AMT Corporate Governance Statement-AMT.AX 30/08/16
AMT Management Change-AMT.AX 30/08/16
AMT Change in substantial holding-AMT.AX 30/08/16
AMT Loan to Progress Bone Substitute Project-AMT.AX PRICE SENSITIVE30/06/16
AMT Details of Company Address-AMT.AX 29/06/16
AMT Promising Results for Sr-HT-Gahnite Bone Substitute-AMT.AX PRICE SENSITIVE07/06/16
AMT Chief Executive Officer's Service Agreement-AMT.AX 02/06/16
AMT Management Changes-AMT.AX PRICE SENSITIVE20/04/16
AMT Half Yearly Report and AccountsPRICE SENSITIVE24/02/16
AMT Update on Outsourcing of ManufacturingPRICE SENSITIVE04/02/16
AMT Chief Executive Officer's Service Agreement23/12/15
AMT Initial Director's Interest Notice18/11/15
AMT Appointment of Director17/11/15
AMT Outsourcing of Manufacturing04/11/15
AMT Final Director's Interest Notice02/11/15
AMT Management ChangesPRICE SENSITIVE29/10/15
AMT Results of Annual General Meeting28/10/15
AMT Management ChangesPRICE SENSITIVE29/09/15
AMT Proxy Form25/09/15
AMT Notice of AGM25/09/15
AMT Annual Report to shareholders25/09/15
AMT Appendix 4G27/08/15
AMT Corporate Governance Statement27/08/15
AMT Appendix 4E and Annual ReportPRICE SENSITIVE27/08/15
AMT Appendix 3B31/07/15
AMT Cancellation of Shares16/03/15
AMT Appendix 4D and Half-year ReportPRICE SENSITIVE25/02/15
AMT Change of Company Name27/11/14
AMT Results of Meeting26/11/14
AMT Final Director's Interest Notice26/11/14
AMT Initial Director's Interest Notice26/11/14
AMT Director Appointment/Resignation26/11/14
AMT Change in substantial holding20/11/14
AMT Becoming a substantial holder19/11/14
AMT Change of Director's Interest Notice19/11/14
AMT Awarded $1.6M under the NSW Medical Devices FundPRICE SENSITIVE31/10/14
AMT Trading Halt Request30/10/14
AMT Trading HaltPRICE SENSITIVE30/10/14
AMT Half Yearly Report and Accounts
21/02/19PRICE SENSITIVE
AMT Allegra Targets USA Market
21/11/18PRICE SENSITIVE
AMT Results of Meeting
31/10/18
AMT Notice of Annual General Meeting/Proxy Form
01/10/18
AMT Appendix 4G and Corporate Governance Statement
12/09/18
AMT Annual Report to shareholders
11/09/18
AMT Appendix 4E & Full Year Statutory Accounts
23/08/18PRICE SENSITIVE
AMT Sr-HT-Gahnite to be used with kangaroo derived tendons
03/08/18PRICE SENSITIVE
AMT Allegra awarded MTPConnect BioMedTech Horizons Grant
18/04/18PRICE SENSITIVE
AMT Initial Director's Interest Notice
14/03/18
AMT Director Appointment
07/03/18
AMT Half Yearly Report and Accounts
22/02/18PRICE SENSITIVE
AMT Allegra to distribute the LINK product range
14/12/17PRICE SENSITIVE
AMT Appendix 3B
08/12/17
AMT Change of Director's Interest Notice
16/11/17
AMT Change of Director's Interest Notice
16/11/17
AMT Change of Director's Interest Notice
16/11/17
AMT Appendix 3B and Section 708A(5)(e) Notification
09/11/17
AMT Private Placement
09/11/17PRICE SENSITIVE
AMT Results of Meeting
25/10/17
AMT Allegra Orthopaedics Limited Business Update
25/10/17PRICE SENSITIVE
AMT Becoming a substantial holder
05/10/17
AMT Notice of Annual General Meeting/Proxy Form
25/09/17
AMT Annual Report to shareholders
25/09/17
AMT Change in substantial holding
22/09/17
AMT Section 708A(5)(e) Notification
18/09/17
AMT Appendix 3B
13/09/17
AMT Private Placement
08/09/17PRICE SENSITIVE
AMT Appendix 4G
30/08/17
AMT Appendix 4E and Annual Report
29/08/17PRICE SENSITIVE
AMT Sr-HT-Gahnite Bone Substitute Project Update
25/08/17PRICE SENSITIVE
AMT Allegra signs collaboration agreement
17/08/17PRICE SENSITIVE
AMT Change of Director's Interest Notice
20/04/17
AMT Change of Director's Interest Notice
20/04/17
AMT Results of Non-Renounceable Rights Issue
12/04/17
AMT Rights Issue to close on 7 April 2017
04/04/17
AMT Notice under section 708AA of the Corporations Act
16/03/17
AMT Rights Issue Letter to Shareholders
10/03/17
AMT Rights Issue Offer Document
09/03/17PRICE SENSITIVE
AMT Rights Issue Letter to Ineligible Shareholders
09/03/17
AMT Notice under section 708AA of the Corporations Act
09/03/17
AMT Change of Director's Interest Notice
03/03/17
AMT Change in substantial holding
27/02/17
AMT Appendix 3B - Rights Issue
23/02/17
AMT Non-Renounceable Rights Issue
23/02/17PRICE SENSITIVE
AMT Half Yearly Report and Accounts
23/02/17PRICE SENSITIVE
AMT Sr-HT-Gahnite Bone Substitute Project update
10/02/17PRICE SENSITIVE
AMT Company Secretary Appointment/Resignation
19/01/17
AMT Cleansing Statement-Share Placement
13/12/16
AMT Appendix 3B
13/12/16
AMT Results of Annual General Meeting
30/11/16
AMT AGM-Business Update
30/11/16
AMT Appointment of Auditor
23/11/16
AMT Business Update-AMT.AX
31/10/16PRICE SENSITIVE
AMT AGM- Item 6-Independent Expert's Report-AMT.AX
28/10/16
AMT AGM-Proxy Form-AMT.AX
28/10/16
AMT Notice of Annual General Meeting-AMT.AX
28/10/16
AMT Conditional Placement-AMT.AX
17/10/16PRICE SENSITIVE
AMT Update on Bone Substitute Project-AMT.AX
20/09/16PRICE SENSITIVE
AMT Appendix 3B-AMT.AX
20/09/16
AMT Appendix 4G-AMT.AX
30/08/16
AMT Appendix 4E and Annual Report-AMT.AX
30/08/16PRICE SENSITIVE
AMT Corporate Governance Statement-AMT.AX
30/08/16
AMT Management Change-AMT.AX
30/08/16
AMT Change in substantial holding-AMT.AX
30/08/16
AMT Loan to Progress Bone Substitute Project-AMT.AX
30/06/16PRICE SENSITIVE
AMT Details of Company Address-AMT.AX
29/06/16
AMT Promising Results for Sr-HT-Gahnite Bone Substitute-AMT.AX
07/06/16PRICE SENSITIVE
AMT Chief Executive Officer's Service Agreement-AMT.AX
02/06/16
AMT Management Changes-AMT.AX
20/04/16PRICE SENSITIVE
AMT Half Yearly Report and Accounts
24/02/16PRICE SENSITIVE
AMT Update on Outsourcing of Manufacturing
04/02/16PRICE SENSITIVE
AMT Chief Executive Officer's Service Agreement
23/12/15
AMT Initial Director's Interest Notice
18/11/15
AMT Appointment of Director
17/11/15
AMT Outsourcing of Manufacturing
04/11/15
AMT Final Director's Interest Notice
02/11/15
AMT Management Changes
29/10/15PRICE SENSITIVE
AMT Results of Annual General Meeting
28/10/15
AMT Management Changes
29/09/15PRICE SENSITIVE
AMT Proxy Form
25/09/15
AMT Notice of AGM
25/09/15
AMT Annual Report to shareholders
25/09/15
AMT Appendix 4G
27/08/15
AMT Corporate Governance Statement
27/08/15
AMT Appendix 4E and Annual Report
27/08/15PRICE SENSITIVE
AMT Appendix 3B
31/07/15
AMT Cancellation of Shares
16/03/15
AMT Appendix 4D and Half-year Report
25/02/15PRICE SENSITIVE
AMT Change of Company Name
27/11/14
AMT Results of Meeting
26/11/14
AMT Final Director's Interest Notice
26/11/14
AMT Initial Director's Interest Notice
26/11/14
AMT Director Appointment/Resignation
26/11/14
AMT Change in substantial holding
20/11/14
AMT Becoming a substantial holder
19/11/14
AMT Change of Director's Interest Notice
19/11/14
AMT Awarded $1.6M under the NSW Medical Devices Fund
31/10/14PRICE SENSITIVE
AMT Trading Halt Request
30/10/14
AMT Trading Halt
30/10/14PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
2.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.468M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AMT (ASX) Chart

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.